UGI (NYSE: UGI) insider transactions
In the twelve months to 10 November 2026, executives and directors of UGI reported 7 open-market sales of 98,209 shares ($3.6m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 31 October 2026 | Flexon Robert C | President and CEO | Option exercise | +43,585 | — | 43,585 | Form 4 |
| 31 October 2026 | Flexon Robert C | President and CEO | Shares withheld for tax | −15,354 | $38.67 | 28,231 | Form 4 |
| 31 October 2026 | Longhi Mario | Director | Option exercise | +21,313 | — | 86,375 | Form 4 |
| 31 October 2026 | Longhi Mario | Director | Shares withheld for tax | −6,091 | $38.67 | 80,284 | Form 4 |
| 18 June 2026 | Shea-Ballay Kathleen | GC and Chief Legal Officer | Option exercise | +25,360 | $24.60 | 25,360 | Form 4 |
| 18 June 2026 | Shea-Ballay Kathleen | GC and Chief Legal Officer | Open-market sale | −25,360 | $33.62 | 0 | Form 4 |
| 10 April 2026 | O'Brien Sean | Chief Financial Officer | Option exercise | +5,660 | — | 5,660 | Form 4 |
| 10 April 2026 | O'Brien Sean | Chief Financial Officer | Shares withheld for tax | −1,576 | $37.94 | 4,084 | Form 4 |
| 11 February 2026 | Tematio Jean Felix | VP, CAO & Corporate Controller | Option exercise | +12,840 | $24.60 | 19,792 | Form 4 |
| 11 February 2026 | Tematio Jean Felix | VP, CAO & Corporate Controller | Open-market sale | −12,840 | $38.07 | 6,952 | Form 4 |
| 30 January 2026 | Dosch Ted A | Director | Grant or award | +4,364 | — | 36,096 | Form 4 |
| 30 January 2026 | Longhi Mario | Director | Grant or award | +7,480 | — | 30,792 | Form 4 |
| 30 January 2026 | Harris Alan N | Director | Grant or award | +4,364 | — | 33,377 | Form 4 |
| 30 January 2026 | Bort M Shawn | Director | Grant or award | +4,364 | — | 85,478 | Form 4 |
| 30 January 2026 | Romano Kelly A | Director | Grant or award | +4,364 | — | 30,005 | Form 4 |
| 30 January 2026 | Faraca Tina Veronica | Director | Grant or award | +4,364 | — | 12,303 | Form 4 |
| 30 January 2026 | Seage Santiago | Director | Grant or award | +4,364 | — | 16,585 | Form 4 |
| 30 January 2026 | Ruiz Melanie | Director | Grant or award | +4,364 | — | 11,275 | Form 4 |
| 30 January 2026 | Bingenheimer David | Director | Grant or award | +4,364 | — | 11,275 | Form 4 |
| 11 January 2026 | Hartz Joseph L. | President of Subsidiary | Option exercise | +4,390 | — | 37,882 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the UGI page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.